Oxford, United Kingdom - 7th July 2025 - OMass Therapeutics (‘OMass’ or ‘the Company’), a biotechnology company identifying ...

Long-term efficacy and safety data on PALSONIFYTM (paltusotine) in acromegaly to be presented, including evidence of both ...

Lundbeck today announces that orphan drug designation has been granted to Lu AG13909 by the US Food and Drug Administration (FDA) on 12 May 2025 and the European Medicines Agency (EMA) on 20 June 2025 ...

VALBY, Denmark, June 24, 2025 Congenital adrenal hyperplasia (CAH) is a rare autosomal recessive disease 1 with an estimated global incidence of approximately 1 in 14,000–18,000 live births 2 ...

Medera and its subsidiary Novoheart have collaborated with scientists at the University of California San Diego School of ...

Hormonal disorders in children can have significant physical, emotional, and social impacts. These conditions can affect ...

With the notable exceptions of Novo Nordisk A/S (NYSE: NVO) and Eli Lilly & Co. (NYSE: LLY), biotechnology stocks had a rough ...

Surgeons transplanted a donor heart into a young boy, transforming him from a frail patient into a lively kid. When Sarah Lee ...

Devi is one of just two athletes without arms to take home a bronze medal from the Paralympic Games. But this 18-year-old ...